The Role of Antenatal Immunoprophylaxis in the Prevention of Maternal-foetal Anti-Rh(D) Alloimmunisation

Overview

Journal Blood Transfus

Specialty Hematology

Date 2010 Jan 28

PMID 20104273

Citations 28

Authors

Giancarlo Maria Liumbruno

Angelo DAlessandro

Federica Rea

Vanessa Piccinini

Liviana Catalano

Gabriele Calizzani

Simonetta Pupella

Giuliano Grazzini

Affiliations

Soon will be listed here.

Citing Articles

Patient experience and burden of haemolytic disease of the foetus and newborn: a systematic review.

Maurice P, McCallion J, Fitzgibbon M, Barthelmes J, Karmous W, Hardy E BMC Pregnancy Childbirth. 2025; 25(1):114.

PMID: 39905388 PMC: 11792410. DOI: 10.1186/s12884-025-07208-9.

Red Blood Cell Alloimmunization in Pregnancy: A Review of the Pathophysiology, Prevalence, and Risk Factors.

Adani S, Mohd Ashari N, Johan M, Edinur H, Noor N, Hassan M Cureus. 2024; 16(5):e60158.

PMID: 38868295 PMC: 11167514. DOI: 10.7759/cureus.60158.

Maternal red blood cell alloimmunization prevalence in the United States.

Sugrue R, Moise K, Federspiel J, Abels E, Louie J, Chen Z Blood Adv. 2024; 8(16):4311-4319.

PMID: 38662646 PMC: 11372799. DOI: 10.1182/bloodadvances.2023012241.

Immunohaematological conundrums in obstetrics from transfusion services viewpoint in Armed Forces setup.

Jagani R, Kumar S, Pawar A, Dimri U, Biswas A Med J Armed Forces India. 2023; 79(3):280-285.

PMID: 37193527 PMC: 10182281. DOI: 10.1016/j.mjafi.2021.05.017.

Upregulation of miR-181a-5p and miR-125b-2-3p in the Maternal Circulation of Fetuses with Rh-Negative Hemolytic Disease of the Fetus and Newborn Could Be Related to Dysfunction of Placental Function.

Xie X, Jiang M, Xiong Z, Huang X Dis Markers. 2022; 2022:2594091.

PMID: 36188428 PMC: 9519318. DOI: 10.1155/2022/2594091.

References

Thornton J, Page C, Foote G, Arthur G, Tovey L, Scott J . Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin. BMJ. 1989; 298(6689):1671-3. PMC: 1836780. DOI: 10.1136/bmj.298.6689.1671. View

Westhoff C . Molecular testing for transfusion medicine. Curr Opin Hematol. 2006; 13(6):471-5. DOI: 10.1097/01.moh.0000245695.77758.3d. View

Freda V, Gorman J, Pollack W . SUCCESSFUL PREVENTION OF EXPERIMENTAL RH SENSITIZATION IN MAN WITH AN ANTI-RH GAMMA2-GLOBULIN ANTIBODY PREPARATION: A PRELIMINARY REPORT. Transfusion. 1964; 4:26-32. DOI: 10.1111/j.1537-2995.1964.tb02824.x. View

MacKenzie I, Findlay J, Thompson K, Roseman F . Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years. BJOG. 2006; 113(7):839-43. DOI: 10.1111/j.1471-0528.2006.00988.x. View

Harkness M, Freer Y, Prescott R, Warner P . Implementation of NICE recommendation for a policy of routine antenatal anti-D prophylaxis: a survey of UK maternity units. Transfus Med. 2008; 18(5):292-5. DOI: 10.1111/j.1365-3148.2008.00882.x. View

Beliard R . Monoclonal anti-D antibodies to prevent alloimmunization: lessons from clinical trials. Transfus Clin Biol. 2006; 13(1-2):58-64. DOI: 10.1016/j.tracli.2006.03.013. View

Bowman J, Pollock J . Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures. Transfus Med Rev. 1987; 1(2):101-12. DOI: 10.1016/s0887-7963(87)70010-8. View

Tabsh K, LEBHERZ T, Crandall B . Risks of prophylactic anti-D immunoglobulin after second-trimester amniocentesis. Am J Obstet Gynecol. 1984; 149(2):225-6. DOI: 10.1016/0002-9378(84)90202-3. View

Trolle B . Prenatal Rh-immune prophylaxis with 300 micrograms immune globulin anti-D in the 28th week of pregnancy. Acta Obstet Gynecol Scand. 1989; 68(1):45-7. DOI: 10.3109/00016348909087688. View

10.

Scott J, Beer A, GUY L, Liesch M, ELBERT G . Pathogenesis of Rh immunization in primigravidas. Fetomaternal versus maternofetal bleeding. Obstet Gynecol. 1977; 49(1):9-14. View

11.

Flegel W . Blood group genotyping in Germany. Transfusion. 2007; 47(1 Suppl):47S-53S. DOI: 10.1111/j.1537-2995.2007.01310.x. View

12.

Urbaniak S . The scientific basis of antenatal prophylaxis. Br J Obstet Gynaecol. 1998; 105 Suppl 18:11-8. DOI: 10.1111/j.1471-0528.1998.tb10286.x. View

13.

Bowman J, Chown B, Lewis M, Pollock J . Rh isoimmunization during pregnancy: antenatal prophylaxis. Can Med Assoc J. 1978; 118(6):623-7. PMC: 1818025. View

14.

Dunn P . Louise Bourgeois (1563-1636): royal midwife of France. Arch Dis Child Fetal Neonatal Ed. 2004; 89(2):F185-7. PMC: 1756029. DOI: 10.1136/adc.2003.037929. View

15.

Lee D, Contreras M, Robson S, Rodeck C, Whittle M . Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists. Transfus Med. 1999; 9(1):93-7. DOI: 10.1046/j.1365-3148.1999.009001093.x. View

16.

Thomson A, Contreras M, Gorick B, Kumpel B, Chapman G, Lane R . Clearance of Rh D-positive red cells with monoclonal anti-D. Lancet. 1990; 336(8724):1147-50. DOI: 10.1016/0140-6736(90)92767-c. View

17.

MacKenzie I, Roseman F, Findlay J, Thompson K, Jackson E, Scott J . The kinetics of routine antenatal prophylactic intramuscular injections of polyclonal anti-D immunoglobulin. BJOG. 2006; 113(1):97-101. DOI: 10.1111/j.1471-0528.2005.00789.x. View

18.

Kumpel B . Monoclonal anti-D for prophylaxis of RhD haemolytic disease of the newborn. Transfus Clin Biol. 1997; 4(4):351-6. DOI: 10.1016/s1246-7820(97)80040-7. View

19.

Lee D, RAWLINSON V . Multicentre trial of antepartum low-dose anti-D immunoglobulin. Transfus Med. 1995; 5(1):15-9. DOI: 10.1111/j.1365-3148.1995.tb00180.x. View

20.

Bichler J, Schondorfer G, Pabst G, Andresen I . Pharmacokinetics of anti-D IgG in pregnant RhD-negative women. BJOG. 2002; 110(1):39-45. View